Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 280
-2
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation

    This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Backer Badge Funded